[Complete remission of Crohn's disease after high-dose alpha-interferon treatment for malignant melanoma]

Gastroenterol Hepatol. 2016 Jun-Jul;39(6):397-400. doi: 10.1016/j.gastrohep.2015.05.004. Epub 2015 Jun 18.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Combined Modality Therapy
  • Crohn Disease / complications*
  • Crohn Disease / drug therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / pharmacology
  • Interferon-alpha / therapeutic use*
  • Melanoma / complications
  • Melanoma / drug therapy*
  • Melanoma / surgery
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Recombinant Proteins / therapeutic use
  • Remission Induction
  • Skin Neoplasms / complications
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / surgery

Substances

  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins